Skip to main content
. 2020 Dec 25;36(10):1893–1899. doi: 10.1093/ndt/gfaa300

Table 1.

Baseline characteristics (at the time of incident ACEI/ARB use)

Characteristics Valuesa
Age (years), % 73.7 (10.4)
 <40 0.23
 40–49 1.27
 50–59 8.06
 60–69 27.44
 70–79 31.06
 >80 31.93
Male, n (%) 164 629 (96.7)
Race, n (%)
 Black 24 493 (14.39)
 White 4063 (2.39)
 Other 141 710 (83.23)
BMI (kg/m2), % 29.2 (6.5)
 <18.5 0.83
 18.5–25 16.46
 25.0–30 29.46
 >30 29.44
SBP (mmHg), mean (SD) 140.7 (22.8)
DBP (mmHg), mean (SD) 75.5 (13.5)
eGFR (mL/min/1.73 m2), % 49.3 (13.8)
 45–59 46.2
 30–44 22.7
 15–29 5.72
 <15 1.84
Diabetes mellitus, n (%) 72 382 (42.5)
CHF, n (%) 29 659 (17.4)
CAD, n (%) 19 803 (11.6)
PVD, n (%) 38 229 (22.5)
COPD, n (%) 56 112 (33.0)
Cerebrovascular disease, n (%) 35 844 (21.1)
Chronic liver disease, n (%) 8038 (4.7)
Malignancy, n (%) 39 699 (23.3)
ACEI/ARB index year, %
 2005–08 44.09
 2009–11 25.40
 2012–15 30.51
a

Missing data: BMI, 23.8%; SBP, 0.75%; DBP, 0.77%.